0001179110-20-010711.txt : 20201028 0001179110-20-010711.hdr.sgml : 20201028 20201028203624 ACCESSION NUMBER: 0001179110-20-010711 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200605 FILED AS OF DATE: 20201028 DATE AS OF CHANGE: 20201028 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bazemore Todd CENTRAL INDEX KEY: 0001605767 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38150 FILM NUMBER: 201270157 MAIL ADDRESS: STREET 1: C/O DYAX CORP. STREET 2: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001479419 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270604595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 120 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 781-996-5252 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 120 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 edgar.xml FORM 4 - X0306 4 2020-06-05 0 0001479419 Kala Pharmaceuticals, Inc. KALA 0001605767 Bazemore Todd C/O KALA PHARMACEUTICALS, INC. 490 ARSENAL WAY, SUITE 120 WATERTOWN MA 02472 0 1 0 0 Chief Operating Officer Common Stock 2020-10-26 4 A 0 81000 0 A 110000 D Common Stock 2020-06-05 4 P 0 2 13.39 A 2 I By son Common Stock 2020-10-22 4 P 0 40 7.60 A 42 I By son On June 25, 2020, the reporting person was granted performance-based restricted stock unit ("RSUs") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued employment with the Issuer, the RSUs will vest as to 50% of the shares underlying the RSUs on October 26, 2021, the first anniversary of the achievement of the performance condition, and as to the remaining 50% of the shares underlying the RSUs on October 26, 2022, the second anniversary of the achievement of the performance condition. Includes 100,000 unvested RSUs. These transactions are being reported late because these shares were acquired by the reporting person's adult son without the reporting person's knowledge. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. /s/ Eric Trachtenberg, Attorney-in-Fact 2020-10-28